71731-4171 Eribulin Mesylate - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

71731-4171

Brand Name:

Eribulin Mesylate

Generic Name:

Eribulin Mesylate

Dosage Form Name:

INJECTION

Administration Route:

Intravenous

Substances:

Name: ERIBULIN MESYLATE

Strength: 0.5

Unit: mg/mL

Packages:

Code: 71731-4171-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (71731-4171-1) / 2 mL in 1 VIAL, SINGLE-DOSE

Effective Date: March 4, 2025

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Antimitotic Agent

Minor Class:

Furopyrans

Orphan Drug Designation:

Status:

In Use